Electro-Acupuncture Treatment in Patients With Osteoarthritis Of The Knee (EATOAK) (EATOAK)

April 5, 2020 updated by: Javier Mata, Hospital Son Llatzer

Randomized, Double-Blind, Placebo-Controlled Trial, Parallel Design Used To Evaluate Pain, Endocrinologic Variations, Life Quality And Medication Use, After Electro-Acupuncture Treatment In Patients With Osteoarthritis Of The Knee

The purpose of this study is to assess the efficacy of electroacupuncture (EA) on pain control, perception of pain, plasma cortisol and beta-endorphins levels, patient-perceived quality of life and use of pain medications, in people with chronic knee pain.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Previous randomised trials and meta-analyses have shown certain efficacy of acupuncture in some chronic painful conditions, in spite of methodological weaknesses. The hypothalamic-pituitary-adrenal (HPA) axis and the endogenous opioid (EO) system are the mechanisms appear to explain how acupuncture works in part. These systems have been shown to be important mediators of stress, pain and other stimuli. The Osteoarthritis Research International suggest that osteoarthritis (OA) treatment should be multidisciplinary and recommended acupuncture as one of 12 possible non-pharmacological modalities for treating OA.

This study is a randomized, double-blind, placebo-controlled trial, parallel design. 128 out-patients over 50 years with OA of the knee will be recruited from Mallorca, Spain. Participants will be randomly allocated into two groups: placebo/sham acupuncture, non insertion technique, and EA. Acupuncture treatments will be used the Traditional Chinese Medicine (TCM) style. The patients will be evaluated after a period of one month (2 sessions weekly), three months (1session monthly), six months (1 session every 45 days) and again one year later (1 session every 2 months), at the end of the study.

Study Type

Interventional

Enrollment (Actual)

160

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Balear Islands
      • Palma, Balear Islands, Spain, 07198
        • Son LLatzer University Hospital
    • Balearic Islands
      • Palma, Balearic Islands, Spain, 07198
        • Son Llátzer Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

50 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients of either sex with primary osteoarthritis of one or both knees fulfilling diagnostic criteria for osteoarthritis knee laid down by American College of Rheumatology.
  • Patients also had to have a Kellgren-Lawrence (radiologic criterion) score of at least 2 and chronic pain in the knee joint for more than 3 months.

Exclusion Criteria:

  • The patients with secondary osteoarthritis of knees
  • Associated systemic arthropathies, e.g. rheumatoid arthritis and gout
  • Patients on steroids
  • Disease modifying drugs, e.g. methotrexate and azathioprine
  • Patients with recent trauma in the area of acupuncture
  • History of intra articular injection of steroid within last two months
  • Patients missing two or more sessions of electro-acupuncture consecutively were excluded from the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Sham Comparator: placebo/sham acupuncture
There are different types of controls used in acupuncture trials. We used the control described as sham and by some as minimal acupuncture. This group had the same schedule as the electro-acupuncture group. Sham acupuncture was administered, with the same duration and frequency and by the same specialist who performed the non-sham acupuncture. Retractable needles were placed into small adhesive cylinders, so that the needles were supported but did not perforate the skin. The acupuncturist placed the needles at the same points as the non-sham group and used the same pairs of electrodes to simulate the electrical connection.
Electro acupuncture is a relatively new method of treatment in Chinese Medicine. Just as in a regular acupuncture treatment, needles are inserted into acupuncture points but small crocodile clips are then attached to the ends of needles to connect them to an electro-acupuncture device. In traditional acupuncture the inserted needles are manually vibrated to induce a response whilst in electro-acupuncture the bi-phasic current results in a constant (controlled) vibration of the needles and a direct electrical stimulation. The device allows the practitioner to adjust the frequency and intensity of the electric stimulation in a consistent manner which is not operator dependant.
Active Comparator: Electroacupuncture
The electro-acupuncture device was a biphasic pulse generator. It was used with maximum tolerable intensity of current and a frequency of 3 Hz. The points were selected according to the Traditional Chinese Medicine meridian theory to treat knee pain. The points selected were local points St 34, St 35, St 36,Liv 8, Sp 10. One distal point St 44.A total of six needles were inserted into each leg by the acupuncturist (the out come measures were not specifically targeted to whether the patient had one or both knees involved). All patients belonging to this group experienced a De Qi sensation, which is a tingling and numbness sensation upon needling of specific points.
Electro acupuncture is a relatively new method of treatment in Chinese Medicine. Just as in a regular acupuncture treatment, needles are inserted into acupuncture points but small crocodile clips are then attached to the ends of needles to connect them to an electro-acupuncture device. In traditional acupuncture the inserted needles are manually vibrated to induce a response whilst in electro-acupuncture the bi-phasic current results in a constant (controlled) vibration of the needles and a direct electrical stimulation. The device allows the practitioner to adjust the frequency and intensity of the electric stimulation in a consistent manner which is not operator dependant.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes from baseline in visual analogue scale (VAS) and the Western Ontario and McMaster (WOMAC) Universities Osteoarthritis Index pain subscale
Time Frame: baseline and the completion of treatment at 12 weeks.
a continuous scale comprised of a horizontal line, anchored by "no pain" (score of 0) and "worst imaginable pain" (score of 100 [100-mm scale]). (VAS pain intensity score)
baseline and the completion of treatment at 12 weeks.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes from baseline in The Short Form 36 version 2 (SF-36v2) health survey
Time Frame: at 1 month
patient-perceived quality of life
at 1 month
Changes from baseline in The Short Form 36 version 2 (SF-36v2) health survey
Time Frame: at 3 months
patient-perceived quality of life
at 3 months
Changes from baseline in The Short Form 36 version 2 (SF-36v2) health survey
Time Frame: at 6 months
patient-perceived quality of life
at 6 months
Changes from baseline in The Short Form 36 version 2 (SF-36v2) health survey
Time Frame: up to 1 year
patient-perceived quality of life
up to 1 year
Change from baseline in plasma cortisol and beta-endorphins levels
Time Frame: at 1 month
analysis of blood samples
at 1 month
Change from baseline in plasma cortisol and beta-endorphins levels
Time Frame: at 3 months
analysis of blood samples
at 3 months
Change from baseline in plasma cortisol and beta-endorphins levels
Time Frame: at 6 months
analysis of blood samples
at 6 months
Change from baseline in plasma cortisol and beta-endorphins levels
Time Frame: up to 1 year
analysis of blood samples
up to 1 year
Change from Baseline in Goldberg Depression and Anxiety scales
Time Frame: at 1 month
measured with the Goldberg Anxiety and Depression Scale. The Spanish version validated by Montón et al. will be used
at 1 month
Change from Baseline in Goldberg Depression and Anxiety scales
Time Frame: at 3 months
measured with the Goldberg Anxiety and Depression Scale. The Spanish version validated by Montón et al. will be used
at 3 months
Change from Baseline in Goldberg Depression and Anxiety scales
Time Frame: at 6 months
measured with the Goldberg Anxiety and Depression Scale. The Spanish version validated by Montón et al. will be used
at 6 months
Change from Baseline in Goldberg Depression and Anxiety scales
Time Frame: up to 1 year
measured with the Goldberg Anxiety and Depression Scale. The Spanish version validated by Montón et al. will be used
up to 1 year
Change from baseline in WOMAC index
Time Frame: at 1 month
WOMAC scale. There are two questions for stiffness (scale of 0-8) and 17 questions for functional limitation (score range of 0-68). Each question will be answered orally with the following criteria: "none" = 0, "a bit" = 1, "quite a bit" = 2, "a lot" = 3, and "very much" = 4. If two or more questions are unanswered, the scale scores will be declared invalid and not counted.
at 1 month
Change from baseline in WOMAC index
Time Frame: at 6 months
WOMAC scale. There are two questions for stiffness (scale of 0-8) and 17 questions for functional limitation (score range of 0-68). Each question will be answered orally with the following criteria: "none" = 0, "a bit" = 1, "quite a bit" = 2, "a lot" = 3, and "very much" = 4. If two or more questions are unanswered, the scale scores will be declared invalid and not counted.
at 6 months
Change from baseline in WOMAC index
Time Frame: up to 1 year
WOMAC scale. There are two questions for stiffness (scale of 0-8) and 17 questions for functional limitation (score range of 0-68). Each question will be answered orally with the following criteria: "none" = 0, "a bit" = 1, "quite a bit" = 2, "a lot" = 3, and "very much" = 4. If two or more questions are unanswered, the scale scores will be declared invalid and not counted.
up to 1 year
Changes in baseline use of medication
Time Frame: at 1 month
EUROHIS (European Health Survey System) theoretical recommendations and design of a questionnaire
at 1 month
Changes in baseline use of medication
Time Frame: at 3 months
EUROHIS (European Health Survey System) theoretical recommendations and design of a questionnaire
at 3 months
Changes in baseline use of medication
Time Frame: at 6 months
EUROHIS (European Health Survey System) theoretical recommendations and design of a questionnaire
at 6 months
Changes in baseline use of medication
Time Frame: up to 1 year
EUROHIS (European Health Survey System) theoretical recommendations and design of a questionnaire
up to 1 year
Change from baseline in a visual analogue scale (VAS)
Time Frame: at 1 month
a continuous scale comprised of a horizontal line, anchored by "no pain" (score of 0) and "worst imaginable pain" (score of 100 [100-mm scale]). (VAS pain intensity score)
at 1 month
Change from baseline in a visual analogue scale (VAS)
Time Frame: at 6 months
a continuous scale comprised of a horizontal line, anchored by "no pain" (score of 0) and "worst imaginable pain" (score of 100 [100-mm scale]). (VAS pain intensity score)
at 6 months
Change from baseline in a visual analogue scale (VAS)
Time Frame: up to 1 year
a continuous scale comprised of a horizontal line, anchored by "no pain" (score of 0) and "worst imaginable pain" (score of 100 [100-mm scale]). (VAS pain intensity score)
up to 1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Javier Mata, M.D., Anaesthesia Department, Son Llàtzer University Hospital. Palma de Mallorca. Spain

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2015

Primary Completion (Actual)

February 1, 2017

Study Completion (Actual)

November 1, 2017

Study Registration Dates

First Submitted

November 11, 2014

First Submitted That Met QC Criteria

November 20, 2014

First Posted (Estimate)

November 24, 2014

Study Record Updates

Last Update Posted (Actual)

April 7, 2020

Last Update Submitted That Met QC Criteria

April 5, 2020

Last Verified

November 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • ACU-001

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Osteoarthritis, Knee

Clinical Trials on Electroacupuncture

3
Subscribe